Another TGF-beta inhibitory molecule SMAD7 [40] in the 16 TGF-beta pathway genes from the 251 developmental process genes has increased expression in AD than in SCC in all but one datasets (see Additional file 2), which supports the notion that distinctive mechanisms might be used by AD and SCC to suppress TGF-beta pathways. Here, SMAD7 is linked to Alzheimer disease.